ABBOTT LABORATORIES (ABT)

Every figure this model derived for ABT, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-03-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 2,086,000,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-03-31
cash 7,295,000,000 CashAndCashEquivalentsAtCarryingValue 2026-03-31
current assets 25,508,000,000 AssetsCurrent 2026-03-31
current liabilities 18,377,000,000 LiabilitiesCurrent 2026-03-31
equity 52,061,000,000 StockholdersEquity 2026-03-31
interest expense 536,000,000 InterestExpenseNonoperating 2026-03-31
ocf 9,464,000,000 NetCashProvidedByUsedInOperatingActivities 2026-03-31
revenue 45,134,000,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-03-31
sbc 692,000,000 ShareBasedCompensation 2026-03-31

The ratios

The figures themselves rather than their scores — what somebody looking up ABT on one particular measure came for.

RatioValue
cash operating margin21.88
current ratio1.39
current ratio reported1.39
dilution pct0.0
ebit cagr-2.49
ebit yoy8.03
ev ebit26.66
ev owner earnings30.73
ev sales4.55
fcf margin16.35
growth cv1.9
interest cover14.38
net debt ebitda1.09
operating margin17.07
owner earnings margin14.81
revenue growth6.59
revenue growth per share6.59
roic9.8
rule of 4023.66
sbc pct revenue1.53

What to be careful about

What this model itself distrusts about ABT's figures. Written by the derivation as it ran, not added afterwards.